Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present DepoMed, Inc. (NASDAQ: DEPO).

Full DD Report for DEPO

You must become a subscriber to view this report.


Recent News from (NASDAQ: DEPO)

FDA OKs first non-opioid treatment for opioid withdrawal
The FDA approves privately held US WorldMeds LLC's Lucemyra (lofexidine hydrochloride) for the management of opioid withdrawal symptoms in adults who abruptly discontinue opioids. More news on: Endo International plc, Allergan plc, Johnson & Johnson, Healthcare stocks news, Read ...
Source: SeekingAlpha
Date: May, 16 2018 16:44
Starboard Value updates on portfolio changes
Activist investor Starboard Value updates on its holdings at the end of Q1. More news on: Newell Brands Inc., Macerich Co., Cars.com Inc., Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: May, 15 2018 16:00
Midday Gainers / Losers (05/10/2018)
Gainers: ARMO +67% . HEAR +63% . KOSS +34% . VTVT +24% . DEPO +22% . PBH +22% . MRAM +20% . SLDB +18% . MCEP +18% . NCTY +18% . More news on: ARMO BioSciences, Inc., Turtle Beach Corporation, Koss Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 10 2018 12:45
Depomed's (DEPO) CEO Arthur Higgins on Q1 2018 Results - Earnings Call Transcript
Depomed Inc. (DEPO) Q1 2018 Results Earnings Conference Call May 10, 2018, 08:30 AM ET Executives John Thomas - VP, IR and Corporate Communications Arthur Higgins - President and Chief Executive Officer August Moretti - Chief Financial Officer and Senior Vice President Analyst...
Source: SeekingAlpha
Date: May, 10 2018 12:30
Depomed up 21% on Q1 earnings beat
Depomed ( DEPO +21% ) Q1 results ($M): Revenue: 128.4 (+42.0%); Product sales: 44.4 (-50.8% due mainly to license deal with Collegium). More news on: Depomed Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...
Source: SeekingAlpha
Date: May, 10 2018 11:04
Depomed Inc. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Depomed Inc. in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 10 2018 08:25
Depomed beats by $0.12, misses on revenue
Depomed (NASDAQ: DEPO ): Q1 EPS of $0.28 beats by $0.12 . More news on: Depomed Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 10 2018 08:01
Depomed Announces First-Quarter 2018 Financial Results
- Company Confirms Previous 2018 Guidance for Neurology Franchise Net Sales and Non-GAAP Adjusted EBITDA - - Amends Existing Agreement for CAMBIA Line Extension – - Announces New Co-Promotion Agreement for Zipsor – - Begins Enrollment in New Clinical Trial Using ...
Source: GlobeNewswire
Date: May, 10 2018 08:00
Depomed Earnings Preview
Depomed (NASDAQ: DEPO ) reports quarterly earnings tomorrow. Analysts expect revenue of $65.7 million and EPS of $0.17. The revenue estimate implies a 30% decline Q/Q. Investors should focus on the following key items: Will The New Business Model Work? A 30% sequential decline in revenue...
Source: SeekingAlpha
Date: May, 09 2018 19:48
Notable earnings before Thursday's open
ACIW , AMCX , BAM , BIOS , BPMP , BTG , CHH , CLNS , CRL , DEPO , DESP , DSX , DUK , ECOM , EGRX , ENB , GDS , HIMX , HL , ICL , KELYA , KLIC , LHO , MDP , MGA , MIXT , MMS , NICE , NOMD , OMI , PBH , PEGI , PQG , RDUS , SATS , SND , SNR , SPH , TGI , ...
Source: SeekingAlpha
Date: May, 09 2018 17:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-177.537.587.6557.431,022,748
2017-02-0318.0618.1818.398817.87751,032
2017-02-0217.8717.9718.2517.65907,996
2017-02-0118.2017.8918.2317.841,341,063
2017-01-3117.5718.0918.1417.351,254,492

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-14106,770167,52863.7326Short
2018-08-13198,017292,54267.6884Short
2018-08-10287,288393,43173.0212Short
2018-08-09583,788961,57760.7115Short
2018-08-08544,832881,67461.7952Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on DEPO.


About DepoMed, Inc. (NASDAQ: DEPO)

Logo for DepoMed, Inc. (NASDAQ: DEPO)

Not available

 

Contact Information

 

 

Current Management

  • John W. Fara / President, CEO
  • John F. Hamilton / CFO

Current Share Structure

  • Market Cap: $467,402,563 - 05/15/2018
  • Issue and Outstanding: 63,505,783 - 02/23/2018

 


Recent Filings from (NASDAQ: DEPO)

Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 14 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Notice of exempt solicitation. Definitive material
Filing Type: PX14A6GFiling Source: edgar
Filing Date: April, 10 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: April, 10 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 05 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 27 2018

 

 


Daily Technical Chart for (NASDAQ: DEPO)

Daily Technical Chart for (NASDAQ: DEPO)


Stay tuned for daily updates and more on (NASDAQ: DEPO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: DEPO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DEPO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of DEPO and does not buy, sell, or trade any shares of DEPO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/